欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DK/H/2605/001
药品名称Forvel
活性成分
    • naloxone hydrochloride 0.4 mg/ml
剂型Solution for injection/infusion
上市许可持有人Medochemie Ltd. 1-10 Constantinoupoleos Street Limassol 3011 Cyprus
参考成员国 - 产品名称Denmark (DK)
Forvel
互认成员国 - 产品名称
    • Austria (AT)
      FORVEL 0,4 mg/ml Injektions-/Infusionslösung
    • Spain (ES)
    • Portugal (PT)
    • Greece (GR)
      FORVEL
    • Latvia (LV)
      Forvel 0,4 mg/ml šķīdums injekcijām/infūzijām
    • Lithuania (LT)
      FORVEL 0,4 mg / ml injekcinis ar infuzinis tirpalas
    • Estonia (EE)
      FORVEL
    • Bulgaria (BG)
      Forvel
    • Cyprus (CY)
    • Czechia (CZ)
      Forvel 0.4mg/ml solution for injection/infusion
    • Romania (RO)
      FORVEL 0,4 mg/ml soluţie injectabilă/perfuzabilă
    • Slovakia (SK)
      FORVEL 0,4 mg/ml injekčný/infúzny roztok
    • Malta (MT)
    • Croatia (HR)
      Forvel 0,4 mg/ml otopina za injekciju/infuziju
许可日期2017/06/26
最近更新日期2023/01/19
药物ATC编码
    • V03AB15 naloxone
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase